In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Academy Member Steven Gross Wins Five-Year Extension of $2.5 Million MERIT Award

The Weill Cornell Medical College pharmacology professor is on the Academy's Biochemical Pharmacology Discussion Group steering committee and helps run metabolomics events at the Academy.

Published March 28, 2011

The NIH has approved a five-year extension of a major grant to Academy member Steven Gross, professor of pharmacology at Weill Cornell Medical College, to study vascular dysfunction associated with diabetes.

Gross, who is a member of the steering committe for the Academy's Biochemical Pharmacology Discussion Group, was selected by the National Heart, Lung and Blood Institute in 2007 to receive a $2.5 million National Institutes of Health Method to Extend Research in Time Award.

Gross, who is also the director of the mass spectrometry core facility at Weill Cornell, is a leading authority and pioneer in mechanisms of signaling by the molecule nitric oxide.